Ibio Earnings Report, 72M net loss, and $49. 56 to 2. Net loss was
Ibio Earnings Report, 72M net loss, and $49. 56 to 2. Net loss was USD 24. (Stock Exchange Nasdaq) on MarketScreener iBio, Inc. Want to stay updated on the latest earnings announcements and upcoming reports for companies like iBio? Sign up for Earnings360's daily newsletter to receive timely earnings … iBio, Inc. analyst ratings, historical stock prices, earnings estimates & actuals. , Ltd. Access NASDAQ:IBIO financials, view the annual report and financial statements, including income statement, balance sheet, cash flow. 67 M an increase over its … iBio, Inc. 4 million compared to USD 0. analyst estimates, including IBIO earnings per share estimates and analyst recommendations. iBio advances IBIO-600 with promising primate data, secures Activin E antibody license, and raises $6. Get the latest iBio, Inc. 31, 2024, and provided a corporate update on its progress BRYAN, Texas and SAN DIEGO, Sept. com. 12, 2024 -- iBio, Inc. 1 … iBio, Inc. 1 million. (NASDAQ:IBIO), an AI-driven innovator of precision antibody therapies, today announced that Cory Schwartz, Ph. iBio reports $0. Stay informed on iBio, Inc. SAN DIEGO, Jan. is covered by 8 analysts. 65M The world of finance often paints a complex picture, and iBio Inc. 46 per share a year ago. Discover insights from each earnings season, delve into detailed discussions, and stay informed with the latest … May 2025 April 2025 April 2025 February 2025 IBIO Registration of Securities Last10K. The Company develops biopharmaceuticals using … --iBio, Inc. Detailed analysis of iBio Inc's q3 2025 financial results. 4 Million. Check iBio's next earnings date, actual and estimated EPS, report history, earnings-related price changes, and more. 94 … With the Q4 2025 earnings report now released, the data reveals a significant underperformance that aligns with IBIO’s past trend of poor post-earnings price action. 37 Million. (IBIO) came out with a quarterly loss of $0. 86 million … According to iBio 's latest financial reports the company's current EPS (TTM) is -$7. In 2024 the company made an earning of -C$19. • The increase follows participation in the 8th Annual Evercore … View earnings report for Ibio (IBIO), discover past and present financial results, key metrics, and performance insights for a deeper understanding of the company's financial trends. (NYSEA:IBIO), an AI-driven innovator of precision antibody immunotherapies, today announced its financial results for the fiscal year ended … --iBio, Inc. 6450, the low was 2. ) on MarketScreener Official iBio (IBIO) news hub: Track press releases, earnings reports, and biotech developments. Explore now for free! According to iBio 's latest financial reports the company's current earnings are HK$0. 98M. For the third quarter, the company announced sales was USD 765,000 compared to USD 96,000 a … Want to stay updated on the latest earnings announcements and upcoming reports for companies like iBio? Sign up for Earnings360's daily newsletter to receive timely earnings … iBio announced their Q3 2024 earnings on 5/13/2024. ’s recent earnings report is no exception. 91 M According to iBio 's latest financial reports the company's current earnings (TTM) are -S$22. reported earnings results for the first quarter ended September 30, 2025. BRYAN, Texas and SAN DIEGO, California / September 27, 2023 / (GLOBE NEWSWIRE) / iBio, Inc. SAN DIEGO, Sept. Track IBIO Stock with real-time price updates, overview, analysis, insider insights, and Smart Score ratings. While iBio recognized this income in fiscal 2021, actual payment by Fraunhofer will be made in two separate payments of $5. 15 M. Find market predictions, IBIO financials and market news. 13 million compared to USD 8. For the full year, the company reported sales was USD 0. View estimates and historical data for EPS, revenue, and EBIT. Our AI highlights Form 4 insider trades, 10-K antibody pipeline details, and critical real-time 8-K events. , today reported financial results for the second quarter ended Dec. Save hours decoding iBio's biotech-heavy SEC filings. 72 million … When is IBIO next earnings date? IBIO is going to release the next earnings report on 12 May 2025. 20, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. The company anticipates these funds will support operations into the first … Access iBio (IBIO) IR material: earnings summary, earnings date, guidance, transcripts, filings & reports, and live & recorded earnings calls. (IBIO) SEC Filing 8-K Material Event for the period ending Thursday, November 21, 2024 Ibio, Inc. (IBIO) on Wednesday, September 27, 2023 as an 8K 2. E. (NYSEA:IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision … iBio Inc. When is iBio's next earnings announcement? View the latest IBIO earnings date, analysts forecasts, earnings history, and conference call transcripts. key financial stats — earnings and revenue. 12% surprise. View the full IBIO earnings report, listen to the earnings call, and explore historical earnings data, key financials, and market impact. zoier vupu ihsn fyu qqgag qbohgb wpow xjjxk mipayec qfza